Suchen Sie nach Informationen zu Unternehmenszentrale Von Grifols USA? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.
https://www.grifols.com/en/usa
2410 Lillyvale Ave. Los Angeles, CA. 90032-3514. USA. Contact information. Tel: 888-GRIFOLS. (888-474-3657) Notification of adverse reactions. To report an adverse drug reaction click here.
https://www.grifols.com/en/home
Innovating for patients and society. Since our founding in 1909, we have applied our ever-growing mastery of plasma science, our ethical leadership and best-in-industry- quality and safety standards to make a healthier and more sustainable society. Read more.
https://www.drugs.com/manufacturer/grifols-usa-llc-521.html
Grifols USA, LLC manufactures, markets and/or distributes more than 17 drugs in the United States. ... Generic name: antihemophilic factor/von willebrand factor Drug class: miscellaneous coagulation modifiers Alphanine SD Generic name: coagulation factor ix Drug class: miscellaneous coagulation modifiers 1 review: 9.0 / 10: Flebogamma
https://www.dnb.com/business-directory/company-profiles.grifols_worldwide_operations_usa_inc.66c994c714cdc98fbbb69e7eaf09b60d.html
Address: 5555 Valley Blvd Los Angeles, CA, 90032-3520 United States See other locations Phone: ? Website: www.grifols.com
https://www.dnb.com/business-directory/company-profiles.grifols.846a74415da7a30e5fa9a1e2d4bf21b8.html
Address: 201 Carlson Cir San Marcos, TX, 78666-6983 United States See other locations Phone: (323) 225-2221 Website: www.grifols.com
https://www.bloomberg.com/profile/company/0007684D:US
Company profile page for Grifols USA Inc including stock price, company news, press releases, executives, board members, and contact information
We shape the future of healthcare through innovation, collaboration and determination. Our people transform lives and make a difference every day, while developing professionally in a growing business Grifols Jobs
https://www.bloomberg.com/profile/company/0958992D:US
Company profile page for Grifols Worldwide Operations USA Inc including stock price, company news, press releases, executives, board members, and contact information
https://www.zoominfo.com/c/grifols-sa/16778315
Grifols 2021 Annual Report on Form 20-F filed with the SEC on April 29, 2022 BARCELONA, Spain, April 29, 2022 /PRNewswire/ -- Grifols, S.A. ("Grifols") (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS) announced that it has filed its 2021 Annual Report on Form 20-F with the United States Securities and Exchange Commission ("SEC") on April 29, 2022.
Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Unternehmenszentrale Von Grifols USA gefunden haben.
